Daniel E Handley insider trades: Predictive Oncology (POAI) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Daniel reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 15, 2022 | POAI | ↑ Buy | 6,000 | $0.41 | $2K | Direct | Dec 15, 2022 (0d) |
| Nov 29, 2022 | POAI | ↑ Buy | 10,000 | $0.36 | $4K | Direct | Nov 30, 2022 (1d) |
| May 26, 2022 | POAI | ↑ Buy | 2,550 | $0.37 | $955 | Direct | May 27, 2022 (1d) |
| May 25, 2022 | POAI | ↑ Buy | 2,800 | $0.35 | $980 | Direct | May 25, 2022 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Daniel E Handley's insider trades
Daniel E Handley is a director at Predictive Oncology (POAI). Since May 25, 2022, Daniel has reported 4 open-market purchases worth $8K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (20 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every POAI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.